February 12, 2018 / 8:04 PM / in 12 days

BRIEF-Pacira Pharma says FDA Posts Briefing Documents For Advisory Meeting Reviewing SNDA For Exparel

Feb 12 (Reuters) - Pacira Pharmaceuticals Inc:

* PACIRA PHARMACEUTICALS INC - FDA POSTS BRIEFING DOCUMENTS FOR ADVISORY MEETING REVIEWING SNDA FOR EXPAREL AS A NERVE BLOCK FOR REGIONAL ANALGESIA

* PACIRA PHARMACEUTICALS INC - ‍PRESCRIPTION DRUG USER FEE ACT DATE FOR COMPLETION OF FDA‘S REVIEW OF COMPANY‘S SNDA FOR EXPAREL IS APRIL 6, 2018​

* PACIRA PHARMACEUTICALS INC - ADVISORY COMMITTEE MEETING IS SCHEDULED FOR FEBRUARY 14-15, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below